Diagnosis of bladder cancer with urinary cytology, immunocytology and DNA-image-cytometry

Analytical Cellular Pathology

Volumn 22, Issue 3, 2001, Pages 103-109

  Planz, Bernhard ^a   Synek, Christian ^a   Deix, Thomas ^a   Böcking, Alfred ^b   Marberger, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

486p 3 12 antigen; Bladder cancer; DNA and flow cytometry; Lewis X antigen; Urinary cytology

Indexed keywords

ANTIBODY; ANTIGEN; DNA; MONOCLONAL ANTIBODY;

ANEUPLOIDY; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CONTROLLED STUDY; CYSTOSCOPY; DNA CONTENT; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINE; URINE CYTOLOGY;

EID: 0034927974     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/703731     Document Type: Article

References (41)

1. Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells
2. A PC-based, semi-expert cytometric system as a diagnostic aid in clinical routine pathology
3. Algorithm for a DNA-cytophotometric diagnosis and grading of malignancy
4. Diagnostic DNA cytometry of the urothelium
5. DNA-measurements, When and why?
6. Consensus report of the ESACP task force on standardization of diagnostic DNA image cytometry
7. Static DNA cytometry
8. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells
9. Urothelial tumors of the urinary tract
10. Automated Feulgen staining with a temperature-controlled staining machine
11. Flowcytometric analysis of DNA content in human bladder tumors and irrigation fluids
12. Monoclonal antibodies against transitional carcinoma for detection of malignant urothelial cells in bladder washing
13. Immunoanatomic distribution of blood group antigens in human urinary tract. Influence of secretory status
14. Blood group related antigens in human urothelium, enhanced expression of precursor, Le, and Le determinants in urothelial carcinoma
15. Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors
16. The heterogenous nature of metastatic neoplasm. Implications of the treatment of cancer
17. Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies
18. Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine
19. Deoxyribonucleic acid measurements in transitional cell carcinomas. Comparision of flow and image cytometry techniques
20. Biological behaviour and DNA cytophotometry of urothelial bladder carcinoma
21. Quantitative immunocytology in the management of patients with superficial bladder carcinoma. A marker to identify patients who do not require prophylaxis
22. Monoclonal antibody 486p 3/12: A valuable bladder carcinoma marker for immunocytology
23. Sensitivity of urinary quantitative immunocytology with monoclonal antibody 486p 3/12 in 241 unselected patients with bladder carcinoma
24. Cancer statistics 1998
25. Tumor-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladder
26. Einsatz der mehrparameter-durchflußzytometrie zur automatischen identifizierung maligner blasentumorzellen
27. Immunocyt, a new tool for detecting transitional cell cancer of the urinary tract
28. TV Cytometer CM 1 for computer aided tumor diagnosis
29. Flowcytometric analysis of DNA-content in bladder cancer, prognostic value of the DNA-index with respect to early tumor recurrence in G2 tumours
30. Use of Lewis X antigen and deoxyribonucleic acid image cytometry to increase sensitivity of urinary cytology in transitional cell carcinoma of the bladder
31. Image cytometric DNA analysis in transitional cell carcinoma of the urinary bladder
32. DNA-aneuploidy as marker for neoplasia in Glurothelial carcinomas
33. Immunostaining of Lewis X from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors
34. High molecular weight glycoproteins human teratocarcinoma defined by monoclonal antibodies carbohydrate determinants
35. Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens
36. Monoclonal antibody Due ABC 3 directed against transitional cell carcinoma, II. Prospective trial on the diagnostic value of immunocytology using monoclonal antibody Due ABC 3
37. Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation
38. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours, a study of 100 untreated cases
39. Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer
40. Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors
41. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?